BCRX
BioCryst Pharmaceuticals (BCRX)
$48
About BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Details
Daily high
$9.48
Daily low
$9.10
Price at open
$9.18
52 Week High
$10.32
52 Week Low
$6.00
Market cap
2.3B
Dividend yield
0.00%
Volume
2.8M
Avg. volume
4.3M
P/E ratio
-5.14
BioCryst Pharmaceuticals News
Details
Daily high
$9.48
Daily low
$9.10
Price at open
$9.18
52 Week High
$10.32
52 Week Low
$6.00
Market cap
2.3B
Dividend yield
0.00%
Volume
2.8M
Avg. volume
4.3M
P/E ratio
-5.14